Torreypines Therapeutics

Drug patent intelligence for strategic decisions on generic entry opportunities

placeSan Diego, California, United States calendar_todayFounded 2000 language torreypinestherapeutics.com

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 187 times.

YearFilings
20121
20131

Investor mix

10 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital550%
Private equity220%
Other / undisclosed330%
Coming soon